JMVRX | MVCAX | JMVRX / MVCAX | |
Total Expense Ratio | 0.70 | 0.99 | 71% |
Annual Report Gross Expense Ratio | 0.79 | 1.00 | 79% |
Fund Existence | 9 years | 24 years | - |
Gain YTD | -1.664 | -1.369 | 122% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.6B | 16.8B | 75% |
Annual Yield % from dividends | 0.97 | 0.90 | 108% |
Returns for 1 year | -5.56 | -4.35 | 128% |
Returns for 3 years | -10.37 | 0.31 | -3,377% |
Returns for 5 years | 49.61 | 96.65 | 51% |
Returns for 10 years | N/A | 56.43 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GNOM | 7.98 | 0.21 | +2.70% |
Global X Genomics & Biotechnology ETF | |||
DDM | 92.37 | 1.03 | +1.13% |
ProShares Ultra Dow30 | |||
XJUN | 38.71 | 0.19 | +0.49% |
FT Vest US Eq Enh&Mod Bffr ETF June | |||
ETEC | 19.51 | N/A | N/A |
iShares Breakthrough Envirtl Sol ETF | |||
BDJ | 8.62 | -0.01 | -0.12% |
BlackRock Enhanced Equity Dividend Trust |